Acta dermato-venereologica最新文献_第6页

Efficacy and Safety of Dupilumab vs Narrowband UVB for the Treatment of Chronic Hand Dermatitis: A Retrospective Study. Dupilumab与窄带UVB治疗慢性手部皮炎的疗效和安全性：一项回顾性研究

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-26 DOI: 10.2340/actadv.v105.42198

Miranda K Branyiczky, Noor Sakka, Mohammed Bawazir, Ajith Cy, Mohannad Abu-Hilal

引用次数: 0

Coalescing Papules on the Pubis in an Ovarian Carcinoma: A Quiz. 卵巢癌患者耻骨上的合并丘疹：一个小测验。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-21 DOI: 10.2340/actadv.v105.43554

Pauline Hirtz, Fanny Belzung, Eurydice Angeli, Marie Beylot-Barry

引用次数: 0

Dermoscopic Features of a CRTC1::TRIM11 Cutaneous Tumour: A Case Report and Literature Review. CRTC1::TRIM11皮肤肿瘤的皮肤镜特征：1例报告及文献复习。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-21 DOI: 10.2340/actadv.v105.43689

Monji Koga, Kaori Koga, Yoshitsugu Shibayama, Shinichi Imafuku

引用次数: 0

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry. Upadacitinib治疗中重度特应性皮炎：来自TREATgermany注册的中期分析结果

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-21 DOI: 10.2340/actadv.v105.42206

Barbara Kind, Luise Heinrich, Thomas Werfel, Jochen Schmitt, Stephan Weidinger

引用次数: 0

Two Cases of Widespread Erythema with Mucosal Lesions: A Quiz. 广泛性红斑伴粘膜病变2例：一个小测验。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-20 DOI: 10.2340/actadv.v105.43386

Sayaka Suzuki, Haruna Kimura, Ryota Hayashi, Natsumi Hama, Riichiro Abe

引用次数: 0

Consistently Reproducible Fixed Drug-induced Urticaria in a Patient with Metastatic Melanoma Under Immunotherapy. 在接受免疫治疗的转移性黑色素瘤患者中持续可重复的固定药物诱导荨麻疹。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-20 DOI: 10.2340/actadv.v105.43652

Thilo Gambichler, Sera S Weyer-Fahlbusch, Sonja Dengler, Jörg Schaller, Laura Susok

引用次数: 0

Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach. 特应性皮炎和银屑病患者生活质量的决定因素：多因素分析。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-19 DOI: 10.2340/actadv.v105.42794

Carsten Spitzer, Ines Buchholz, Laura Lübke, Clara Wülfing, Katharina Meier, Georgios Kokolakis, Dennis Niebel, Caroline Mann, Ante Karoglan, Steffen Emmert, Alexander Thiem

{"title":"Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach.","authors":"Carsten Spitzer, Ines Buchholz, Laura Lübke, Clara Wülfing, Katharina Meier, Georgios Kokolakis, Dennis Niebel, Caroline Mann, Ante Karoglan, Steffen Emmert, Alexander Thiem","doi":"10.2340/actadv.v105.42794","DOIUrl":"10.2340/actadv.v105.42794","url":null,"abstract":"Health-related quality of life (HRQoL) is reduced in atopic dermatitis and psoriasis. Several factors impact HRQoL including sociodemographic and skin disease-related characteristics, health behaviours, cardiometabolic comorbidities, and psychological conditions. However, their differential and unique effects on HRQoL are not well studied. In this cross-sectional online survey, adult patients with atopic dermatitis (n = 155) or psoriasis (n = 246) provided data on features of their respective skin diseases, health behaviours, and cardiometabolic comorbidities. Validated self-report measures assessed HRQoL, psychopathology (Patient Health Questionnaire-4), and stress (Perceived Stress Scale). Linear regression analyses were used to determine key predictors of HRQoL. In atopic dermatitis, linear regression analyses revealed that self-rated disease severity (Patient-Oriented Eczema Measure), anxiety, and stress were significant predictors of the Dermatology Life Quality Index (DLQI), explaining 59% of the variance. In psoriasis, disease severity (Psoriasis Symptoms and Signs Diary) and depression significantly predicted DLQI, with an explained variance of 57%. Health behaviours and cardiometabolic comorbidities did not impact DLQI scores. While skin disease severity is the most important determinant of HRQoL, stress and anxiety are important in atopic dermatitis, whereas depression is relevant in psoriasis. These findings hold implications for both clinical practice and research.","PeriodicalId":6944,"journal":{"name":"Acta dermato-venereologica","volume":"105 ","pages":"adv42794"},"PeriodicalIF":3.5,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144100988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Paxbp1 is Indispensable for the Maintenance of Hair Follicle Homeostasis. Paxbp1对毛囊内稳态的维持是不可缺少的。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-19 DOI: 10.2340/actadv.v105.43648

Cong Huang, Wenting Li, Shizheng Zhao, Wei Zhang, Bo Yu

引用次数: 0

Leukotriene Receptor Antagonists for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis. 白三烯受体拮抗剂治疗特应性皮炎：系统回顾和荟萃分析。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-19 DOI: 10.2340/actadv.v105.43140

Safa Fawaza Mahmood, Wafa Nawafa Mahmood, Omnia Mohamed Abdalla, Afra Nazar, Hadeeqah Zayaan Riaz, Soha Elmorsy

{"title":"Leukotriene Receptor Antagonists for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis.","authors":"Safa Fawaza Mahmood, Wafa Nawafa Mahmood, Omnia Mohamed Abdalla, Afra Nazar, Hadeeqah Zayaan Riaz, Soha Elmorsy","doi":"10.2340/actadv.v105.43140","DOIUrl":"10.2340/actadv.v105.43140","url":null,"abstract":"Atopic dermatitis is a chronic skin condition with no cure. Current conventional treatments can have many side effects or are expensive. Emerging evidence suggests leukotriene receptor antagonists could serve as a corticosteroid-sparing option. This meta-analysis examined 26 studies on the efficacy of leukotriene receptor antagonists for treating atopic dermatitis across 742 participants. There were non-significant reductions in atopic dermatitis severity overall. However, in subgroup analyses montelukast significantly reduced Severity Scoring of Atopic Dermatitis scores in adult populations (SMD = -0.94, 95% CI -1.35 to -0.54, p < 0.0001) and also when compared with conventional treatment rather than placebo (SMD = -0.84, 95% CI -1.21 to -0.47, p < 0.0001). Studies excluded from the statistical analysis generally showed a positive trend favouring montelukast, even if results were not statistically significant. Montelukast shows potential as an adjunct therapy in atopic dermatitis, particularly in adults, but its efficacy is inconsistent. While it may help with pruritus, it should not replace standard treatments. Future research should focus on standardized assessments and personalized approaches to clarify its role in atopic dermatitis management.","PeriodicalId":6944,"journal":{"name":"Acta dermato-venereologica","volume":"105 ","pages":"adv43140"},"PeriodicalIF":3.5,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144101031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hidradenitis Suppurativa and Ocular Diseases: Real-world Evidence of 57,972 Patients. 化脓性汗腺炎和眼部疾病：57,972例患者的真实证据。

IF 3.5 4区医学

Acta dermato-venereologica Pub Date : 2025-05-19 DOI: 10.2340/actadv.v105.42716

Jennifer Von Stebut-Marx, Robert Preissner, Sylke Schneider-Burrus, Saskia Preissner

{"title":"Hidradenitis Suppurativa and Ocular Diseases: Real-world Evidence of 57,972 Patients.","authors":"Jennifer Von Stebut-Marx, Robert Preissner, Sylke Schneider-Burrus, Saskia Preissner","doi":"10.2340/actadv.v105.42716","DOIUrl":"10.2340/actadv.v105.42716","url":null,"abstract":"Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurring dermal abscesses and cutaneous fistulas of intertriginous skin regions, significantly impacting patients' quality of life. While HS has been associated with various comorbidities such as metabolic and chronic inflammatory diseases, many systemic effects of this systemic disease remain to be investigated. In this study, 2 cohorts of patients with and without HS were created - matched for sex, age, and nicotine dependence - each comprising 28,986 patients, using the real-world database TriNetX, to investigate the association of ocular diseases and HS. Not only an increased risk of disorders of refraction and accommodation in HS patients (OR 3.466; 95% CI 3.100, 3.876), but also a higher risk of ocular diseases, including disorders of the lacrimal system, was demonstrated when compared with the control cohort (OR 3.523; 95%CI 2.912, 4.263). Although previous studies have suggested an increased risk of ocular comorbidities in HS patients, ocular history is not routinely queried during visits. Here, the need for further exploration of the association of ocular diseases and HS and for incorporating this into clinical practice is emphasized.","PeriodicalId":6944,"journal":{"name":"Acta dermato-venereologica","volume":"105 ","pages":"adv42716"},"PeriodicalIF":3.5,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144101000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0